Stock Price
P/E Ratio
Volume Traded Today
Dividend
52 Week High/low
Canopy Growth Corp Market Cap
From what 10 stock analysts predict, the share price for Canopy Growth Corp (CGC) might decrease by 33.36% in the next year. This is based on a 12-month average estimation for CGC. Price targets go from $1.38316 to $3.07756. The majority of stock analysts believe CGC is a hold. Please note analyst price targets are not guaranteed and could be missed completely.
About 10 Wall Street analysts have assigned CGC 1 buy ratings, 6 hold ratings, and 3 sell ratings. This means that analysts expect Canopy Growth Corp to generate similar returns as the market. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on CGC. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.
These are the latest 20 analyst ratings of CGC.
|
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
|---|---|---|---|---|
| Michael Lavery Piper Sandler | Underweight | $2 | Maintains | Jul 9, 2024 |
| Lisa Lewandowski B of A Securities | Underperform | $0.66 | Maintains | Sep 15, 2023 |
| John Zamparo CIBC | Underperformer | $0.5 | Maintains | Jun 12, 2023 |
| Michael Lavery Piper Sandler | Underweight | $1 | Maintains | May 2, 2023 |
| Pablo Zuanic Cantor Fitzgerald | Neutral | $3.2 | Maintains | Feb 17, 2023 |
| Pablo Zuanic Cantor Fitzgerald | Neutral | $3.3 | Maintains | Nov 7, 2022 |
| Nadine Sarwat Bernstein | Underperform | $1.5 | Initiates | Nov 2, 2022 |
| Pablo Zuanic Cantor Fitzgerald | Neutral | $3.05 | Maintains | Oct 26, 2022 |
| Gaurav Jain Barclays | Underweight | $2 | Maintains | Sep 30, 2022 |
| Michael Lavery Piper Sandler | Underweight | $2.5 | Maintains | Aug 8, 2022 |
| Michael Lavery Piper Sandler | Underweight | $3 | Maintains | Jun 30, 2022 |
| Gaurav Jain Barclays | Underweight | $3.5 | Maintains | Jun 8, 2022 |
| Michael Lavery Piper Sandler | Underweight | $4 | Maintains | May 31, 2022 |
Barclays | Underweight | Downgrade | Mar 22, 2022 | |
| Gaurav Jain Barclays | Equal-Weight | $9 | Maintains | Mar 1, 2022 |
| Pablo Zuanic Cantor Fitzgerald | Neutral | $11 | Maintains | Feb 18, 2022 |
| Lisa Lewandowski B of A Securities | Underperform | $10 | Downgrade | Dec 22, 2021 |
| Michael Lavery Piper Sandler | Underweight | $7 | Downgrade | Dec 20, 2021 |
Wells Fargo | Underweight | Initiates | Dec 7, 2021 | |
Barclays | Equal-Weight | Initiates | Nov 18, 2021 |
When did it IPO
2018
Staff Count
1,029
Country
Canada
Sector/Industry
Healthcare/Drug Manufacturers - Specialty & Generic
CEO
Mr. David Eric Klein
Market Cap
$483.6M
In 2023, CGC generated $333.3M in revenue, which was a decrease of -29.94% from the previous year. This can be seen as a signal that CGC's business is declining, and its share price could be worth less in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Mon, 09 Dec 2024
Sentiment - NEUTRAL
Source - PRNewsWire
Summary - Canopy USA has acquired Acreage, consolidating its operations across Wana, Jetty, and Acreage. This move aims to enhance growth and cost efficiencies in U.S. state-legal markets.
Why It Matters - Canopy USA's acquisition of Acreage enables streamlined operations and market expansion, enhancing growth potential in key U.S. markets, which could positively impact stock performance.
Wed, 04 Dec 2024
Sentiment - NEUTRAL
Source - PRNewsWire
Summary - Canopy Growth launched two holiday cannabis products: a sugar-free Cranberry Ginger Ale and Tweed Snowtorious 91K flower, aiming to enhance seasonal celebrations.
Why It Matters - The launch of holiday-themed cannabis products by Canopy Growth could boost sales and brand visibility, potentially impacting stock performance positively during the festive season.
Mon, 02 Dec 2024
Sentiment - NEUTRAL
Source - PRNewsWire
Summary - Canopy Growth is set to acquire Acreage Holdings on or around December 9, 2024, pending closing conditions, as per their arrangement agreement from April 2019.
Why It Matters - The anticipated acquisition of Acreage by Canopy Growth could enhance market share, streamline operations, and improve profitability in the growing cannabis sector, impacting stock valuations positively.
Thu, 28 Nov 2024
Sentiment - POSITIVE
Source - Zacks Investment Research
Summary - Canopy Growth (CGC) is gaining attention from Zacks.com users, indicating potential interest and factors that could affect the stock's performance.
Why It Matters - Heightened interest in Canopy Growth (CGC) signals potential volatility and market movements, affecting stock performance and investment decisions.
Fri, 29 Nov 2024
Sentiment - NEUTRAL
Source - Market Watch
Summary - Cannabis stocks have declined due to stalled U.S. federal legalization. Companies are now exploring THC derived from hemp to create new revenue opportunities.
Why It Matters - Stalled federal legalization is hurting cannabis stocks, prompting companies to pivot to hemp-derived THC, potentially boosting revenue and investor interest in a challenging market.
Tue, 26 Nov 2024
Sentiment - NEGATIVE
Source - Market Watch
Summary - Canopy Growth has appointed Luc Mongeau as CEO, replacing David Klein, amid a 19% stock price decline and consecutive money-losing quarters this year.
Why It Matters - Canopy Growth's leadership change amid declining stock and losses signals potential shifts in strategy, impacting future performance and investor sentiment.
The information that Ticker Nerd provides is general in nature as it has been prepared without taking account of your objectives, financial situation or needs. It is not intended as legal, financial or investment advice and should not be construed or relied on as such. Ticker Nerd is for information purposes only. Ticker Nerd is not responsible for any damages or losses that may occur as a result of reliance on this information. Before making any commitment of a legal or financial nature you should seek advice from a qualified and registered legal practitioner or financial or investment adviser. All content, group, messaging, tweets, newsletter, article, and email created by Ticker Nerd is intended for educational and information purposes only, is not financial, investment, legal or tax advice, and is a restatement, summary or extract of other data and research reports that are widely distributed from sources such as, but not limited to, Bloomberg, Market Watch, Wall Street Journal, Google Finance, and Yahoo Finance. Ticker Nerd is not a registered financial, investment, legal or tax advisor and is not liable for any financial loss you may incur acting on any information provided by Ticker Nerd. By registering, you agree not to hold Ticker Nerd liable at any time or under any circumstances for your decisions, actions, or results.
